Option Care Health, Inc. (OPCH)
NASDAQ: OPCH · Real-Time Price · USD
29.89
-0.01 (-0.03%)
At close: Dec 5, 2025, 4:00 PM EST
29.64
-0.25 (-0.84%)
After-hours: Dec 5, 2025, 5:53 PM EST
Option Care Health Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Option Care Health stock have an average target of 36, with a low estimate of 27 and a high estimate of 41. The average target predicts an increase of 20.44% from the current stock price of 29.89.
Analyst Consensus: Buy
* Price targets were last updated on Nov 3, 2025.
Analyst Ratings
The average analyst rating for Option Care Health stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Hold | 1 | 1 | 1 | 1 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 9 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Hold Maintains $30 → $27 | Hold | Maintains | $30 → $27 | -9.67% | Nov 3, 2025 |
| Citizens | Citizens | Buy Maintains $38 → $36 | Buy | Maintains | $38 → $36 | +20.44% | Oct 31, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $38 | Buy | Maintains | $38 | +27.13% | Oct 31, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $35 | Buy | Initiates | $35 | +17.10% | Oct 17, 2025 |
| TD Cowen | TD Cowen | Hold Initiates $30 | Hold | Initiates | $30 | +0.37% | Oct 2, 2025 |
Financial Forecast
Revenue This Year
5.75B
from 5.00B
Increased by 15.08%
Revenue Next Year
6.18B
from 5.75B
Increased by 7.44%
EPS This Year
1.75
from 1.23
Increased by 42.47%
EPS Next Year
1.91
from 1.75
Increased by 8.91%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 5.9B | 6.5B | |||
| Avg | 5.8B | 6.2B | |||
| Low | 5.5B | 5.8B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 18.6% | 12.7% | |||
| Avg | 15.1% | 7.4% | |||
| Low | 10.3% | 1.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.83 | 2.07 | |||
| Avg | 1.75 | 1.91 | |||
| Low | 1.67 | 1.72 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 48.5% | 18.0% | |||
| Avg | 42.5% | 8.9% | |||
| Low | 35.4% | -1.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.